JPS4995971A - - Google Patents
Info
- Publication number
- JPS4995971A JPS4995971A JP1067173A JP1067173A JPS4995971A JP S4995971 A JPS4995971 A JP S4995971A JP 1067173 A JP1067173 A JP 1067173A JP 1067173 A JP1067173 A JP 1067173A JP S4995971 A JPS4995971 A JP S4995971A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1067173A JPS4995971A (de) | 1973-01-27 | 1973-01-27 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1067173A JPS4995971A (de) | 1973-01-27 | 1973-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4995971A true JPS4995971A (de) | 1974-09-11 |
Family
ID=11756698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1067173A Pending JPS4995971A (de) | 1973-01-27 | 1973-01-27 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4995971A (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1954682A1 (de) * | 2005-11-21 | 2008-08-13 | Astra Zeneca AB | Neue 2-aminoimidazol-4-onverbindungen und ihre verwendung bei der herstellung eines medikaments zur verwendung bei der behandlung von kognitiven schwächen, alzheimer-krankheit, neurodegeneration und demenz |
| WO2014127042A1 (en) * | 2013-02-12 | 2014-08-21 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
-
1973
- 1973-01-27 JP JP1067173A patent/JPS4995971A/ja active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1954682A1 (de) * | 2005-11-21 | 2008-08-13 | Astra Zeneca AB | Neue 2-aminoimidazol-4-onverbindungen und ihre verwendung bei der herstellung eines medikaments zur verwendung bei der behandlung von kognitiven schwächen, alzheimer-krankheit, neurodegeneration und demenz |
| EP1954682A4 (de) * | 2005-11-21 | 2011-11-09 | Astrazeneca Ab | Neue 2-aminoimidazol-4-onverbindungen und ihre verwendung bei der herstellung eines medikaments zur verwendung bei der behandlung von kognitiven schwächen, alzheimer-krankheit, neurodegeneration und demenz |
| WO2014127042A1 (en) * | 2013-02-12 | 2014-08-21 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
| CN104995176A (zh) * | 2013-02-12 | 2015-10-21 | 巴克老龄化研究所 | 调节bace所介导的app加工的乙内酰脲 |
| US9926280B2 (en) | 2013-02-12 | 2018-03-27 | Buck Institute For Research On Aging | Hydantoins that modulate BACE-mediated APP processing |
| US10202355B2 (en) | 2013-02-12 | 2019-02-12 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
| JP2019056012A (ja) * | 2013-02-12 | 2019-04-11 | バック・インスティテュート・フォー・リサーチ・オン・エイジング | Ｂａｃｅ仲介性ａｐｐプロセシングを調節するヒダントイン |
| US10766867B2 (en) | 2013-02-12 | 2020-09-08 | Buck Institute For Research On Aging | Hydantoins that modulate BACE-mediated APP processing |
| US11091444B2 (en) | 2013-02-12 | 2021-08-17 | Buck Institute For Research On Aging | Hydantoins that modulate BACE-mediated app processing |